Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 25 Show results per page	View Search Criteria \| Help With Results


1.		Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Other				06-2247 NCT00442533

Last Modified: 8/1/2008 First Published: 9/23/2005


2.		Phase I/II Pilot Study of Fluorouracil, Leucovorin Calcium, and Oxaliplatin (FOLFOX) With Bevacizumab in Patients With Advanced Neuroendocrine Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				UCSF-04458 NCT00227617

Last Modified: 10/1/2008 First Published: 10/24/2006


3.		Phase I/II Study of Erlotinib Hydrochloride and Cetuximab in Patients With Advanced Gastrointestinal, Head and Neck, Non-Small Cell Lung, or Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				VU-VICC-GI-0622 VICC-GI-0622, 6980, NCI-6980, NCT00397384


4.		Evaluation of Single Session Stereotactic Body Radiotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Not specified				Other				2005-0445 NCT00492817


5.		Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Other				CTCT 06-11 NCT00493883


6.		Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Supportive care, Treatment				Active				Not specified				Other				ID02-446 NCT00508443

Last Modified: 10/6/2008 First Published: 10/25/2004


7.		Phase II Study of Intrahepatic Arterial Infusion of Melphalan With Venous Filtration Via Peripheral Hepatic Perfusion in Patients With Unresectable Primary or Metastatic Liver Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				16 and over				NCI				NCI-04-C-0273 NCI-6332, DELCATH-G990039, NCT00096083


8.		Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				END0002 97273, END0002, NCT00398320, NCT00398320

Last Modified: 10/26/2007 First Published: 3/22/2007


9.		Phase II Study of Pazopanib Hydrochloride in Patients With Low- or Intermediate-Grade Advanced Neuroendocrine Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				21 and over				NCI				MDA-2006-0077 MDACC 2006-0077, 7650, NCT00454363


10.		Lithium for Low-Grade Neuroendocrine Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI, Other				CO07203 NIH R21CA117117-01A2, NCT00501540

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute